Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNK | O75909 | 20/20 | 0.79 |
| ▸ | CDK12 | Q9NYV4 | 20/20 | 0.79 |
| ▸ | CCNE1 | P24864 | 14/20 | 0.79 |
| ▸ | CDK2 | P24941 | 14/20 | 0.79 |
| ▸ | CCNT1 | O60563 | 12/20 | 0.79 |
| ▸ | CDK9 | P50750 | 12/20 | 0.79 |
| ▸ | CDK7 | P50613 | 7/20 | 0.79 |
| ▸ | CCNH | P51946 | 7/20 | 0.79 |
| ▸ | MNAT1 | P51948 | 7/20 | 0.79 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25267992 | 0.92 | CCNK (0.78) | CCNKCDK12CCNE1CDK2CCNT1 | |
| SCHEMBL30204519 | 0.91 | CCNK (0.74) | CCNKCDK12CCNE1CDK2CCNT1 | |
| SCHEMBL26967491 | 0.89 | CCNK (0.80) | CCNKCDK12CCNE1CDK2CCNT1 | |
| SCHEMBL31270040 | 0.88 | CCNK (1.00) | CCNKCDK12CCNE1CDK2CCNT1 | |
| SCHEMBL24839849 | 0.88 | CCNK (1.00) | CCNKCDK12CCNE1CDK2CCNT1 | |
| SCHEMBL25225790 | 0.88 | CCNK (0.67) | CCNKCDK12CCNE1CDK2CCNT1 | |
| SCHEMBL25273646 | 0.87 | CCNK (0.79) | CCNKCDK12CCNE1CDK2CCNT1 | |
| SCHEMBL25258671 | 0.86 | CCNK (0.80) | CCNKCDK12CCNE1CDK2CCNT1 | |
| SCHEMBL25268483 | 0.86 | CCNK (0.80) | CCNKCDK12CCNE1CDK2CCNT1 | |
| SCHEMBL26967495 | 0.86 | CCNK (0.80) | CCNKCDK12CCNE1CDK2CCNT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3484871-B1 | PIPERIDINE DERIVATIVES AS INHIBITORS OF CYCLIN DEPENDENT KINASE 7 (CDK7) | SYROS PHARMACEUTICALS INC (US) | 2023-06-07 | — | — | EP | disclosed |